Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new record history entry 'Revision: v3.7.0' was added to the history, and the prior entry 'Revision: v3.6.6' was removed, updating the study's version history list.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe record history now displays a new revision entry labeled v3.6.6. The previous revision v3.6.5 was removed.SummaryDifference0.1%

- Check53 days agoChange DetectedNew version entry added to the Study Record History: Revision: v3.6.5. This indicates a recent update to the record since the previous version (v3.6.4).SummaryDifference0.1%

- Check67 days agoChange DetectedThe page history now shows a new revision label, updating from Revision: v3.6.3 to Revision: v3.6.4. This indicates a minor update to the page's record.SummaryDifference0.1%

- Check82 days agoChange DetectedTwo new sections, Contacts/Locations and Study Status, were added to the study history page on 2026-07-07, improving access to contact details and the current study status. A prior entry from 2026-06-22 was removed from the history.SummaryDifference0.3%

- Check89 days agoChange DetectedA new revision entry (v3.6.3) was added to the history, replacing the previous v3.6.2. This indicates an incremental update to the study record's documentation.SummaryDifference0.1%

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.